SCHEMBL5898534

SCHEMBL5898534

CCC(=O)c1cc(C(F)(F)F)ccc1C(F)(F)F

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.66
PSMB11 A5LHX3 5/20 0.43
PSMA7 O14818 5/20 0.43
PSMB1 P20618 5/20 0.43
PSMA1 P25786 5/20 0.43
PSMA2 P25787 5/20 0.43
PSMA3 P25788 5/20 0.43
PSMA4 P25789 5/20 0.43
PSMB8 P28062 5/20 0.43
PSMB9 P28065 5/20 0.43
PSMA5 P28066 5/20 0.43
PSMB4 P28070 5/20 0.43
PSMB6 P28072 5/20 0.43
PSMB5 P28074 5/20 0.43
PSMB10 P40306 5/20 0.43
PSMB3 P49720 5/20 0.43
PSMB2 P49721 5/20 0.43
PSMA6 P60900 5/20 0.43
PSMA8 Q8TAA3 5/20 0.43
PSMB7 Q99436 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26056992 0.86 CES2 (0.66) CES2MAPTKDM4EALDH1A1HPGD
SCHEMBL3920354 0.83 CES2 (0.66) CES2PSMB11PSMA7PSMB1PSMA1
SCHEMBL5362040 0.83 CES2 (0.66) CES2PSMB11PSMA7PSMB1PSMA1
SCHEMBL5357587 0.83 CES2 (0.66) CES2PSMB11PSMA7PSMB1PSMA1
SCHEMBL26020578 0.83 CES2 (0.43) CES2ALDH1A1POLQHSP90AB1TMPRSS4
SCHEMBL24450665 0.83 MEN1 (0.47) CES2MAPTKDM4EALDH1A1HPGD
SCHEMBL311232 0.83 CES2 (0.47) CES2MAPTKDM4EALDH1A1HPGD
SCHEMBL28233849 0.81 CES2 (0.46) CES2MAPTKDM4EALDH1A1HPGD
SCHEMBL27920621 0.81 KDM4E (0.51) CES2MAPTKDM4EALDH1A1HPGD
SCHEMBL27643680 0.81 JAK2 (0.50) CES2MAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity MEZA TOLEDO SERGIO E 2006-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity GABRB2, HRH3, HRH4 CES2 146/4885PSMB11 3443/4885PSMA7 3821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.